Table 2.
Treatment-related toxicity
| Toxicity | |||
|---|---|---|---|
| CTCAE category | CTCAE term | Any grade % (No.) |
Grade 3+ % (No.) |
| Blood/lymphatic system | Anemia | 2% (1) | |
| Other | 2% (1) | ||
| Cardiac | Sinus bradycardia | 2% (1) | 2% (1) |
| Gastrointestinal | Abdominal pain | 11% (7) | 2% (1) |
| Bloating | 3% (2) | ||
| Constipaton | 14% (9) | ||
| Diarrhea | 6% (4) | ||
| Dysphagia | 6% (4) | ||
| Nausea | 21% (13) | ||
| Stomach pain | 3% (2) | ||
| Vomiting | 2% (1) | ||
| General | Fatigue | 52% (33) | |
| Pain | 19% (12) | ||
| Injury/procedural complications | Radiation Dermatitis | 33% (21) | |
| Investigations | Hyperbilirubinemia | 2% (1) | 2% (1) |
| Weight loss | 3% (2) | ||
| Metabolism | Anorexia | 24% (15) | |
| Musculoskeletal | Back pain | 6% (4) | 2% (1) |
| Bone pain | 3% (2) | ||
| Respiratory | Cough | 2% (1) | |
| Dyspnea | 6% (4) | ||
| Skin | Hyperpigmentation | 3% (2) | |
CTCAE common terminology criteria for adverse events (version 4)